Moneycontrol PRO
results
Jump to
10 Results Found
  • Pharma cos likely to post 21% EBITDA growth in Q4: MOST Apr 16, 2013 01:30 PM IST

    Pharma cos likely to post 21% EBITDA growth in Q4: MOST

    Motilal Oswal has come with its March`13 quarterly earning estimates for healthcare sector. The research firm expects a top line growth of 17.4% YoY and EBITDA growth of 21.3% YoY for our pharma universe (excluding one-offs).

  • To ease out working capital woes via rejig: Opto Circuits Feb 13, 2013 12:33 PM IST

    To ease out working capital woes via rejig: Opto Circuits

    Opto Circuits posted a net profit decline of 9 percent. In an interview to CNBC-TV18, Vinod Ramnani, CMD, Opto Circuits said that there are working capital problems and the company is looking at restructuring to alleviate the problem.

  • See pharma sector's Q3 topline to grow 22%: Motilal Oswal Jan 12, 2013 11:54 AM IST

    See pharma sector's Q3 topline to grow 22%: Motilal Oswal

    Motilal Oswal has come out with its earnings estimates for pharmaceuticals sector for the quarter ended December 2012. The research firm expects the topline to grow by 22 percent, EBITDA by 21 percent on the back of strong operational performance by Ranbaxy, Glenmark, Strides, Torrent and Divi's.

  • Eyeing better margins in H2FY13: Opto Circuit Nov 15, 2012 03:22 PM IST

    Eyeing better margins in H2FY13: Opto Circuit

    V Bhaskar, Director of Opto Circuits said the company's invasive as well as non-invasive segments have grown well in Q2. Going ahead, he is hopeful of improving margins in the second half of the year.

  • Expect 20% revenue growth in FY13: Opto Circuits May 23, 2012 02:02 PM IST

    Expect 20% revenue growth in FY13: Opto Circuits

    In an interview to CNBC-TV18, V Bhaskar, head of finance of Opto Circuits says, he expects 20% revenue growth in FY13.

  • Opto Circuits Q4 PAT seen up 3% at Rs 114 cr May 21, 2012 06:38 PM IST

    Opto Circuits Q4 PAT seen up 3% at Rs 114 cr

    Opto Circuits is expected to report a growth of 3% year-on-year in its profit after tax of Rs 114 crore for the fourth quarter of FY12, reported CNBC-TV18 poll.

  • Opto Circuits Sept qtr PAT seen up 40% at Rs 109 cr Oct 11, 2011 12:37 PM IST

    Opto Circuits Sept qtr PAT seen up 40% at Rs 109 cr

    Dolat Capital has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Opto Circuits September quarter net sales are expected to go up by 68.3% at Rs 557.6 crore, year-on-year, (YoY) basis.

  • Opto Circuits aims for 30% growth in revenues for FY12 May 18, 2011 11:50 AM IST

    Opto Circuits aims for 30% growth in revenues for FY12

    V Bhaskar the director finance of Opto Circuits spoke to CNBC-TV18 about the results of the company and what the road ahead looked like.

  • Opto Circuits Mar qtr PAT seen up at Rs 74.8 cr: MOST Apr 15, 2011 12:13 PM IST

    Opto Circuits Mar qtr PAT seen up at Rs 74.8 cr: MOST

    Motilal Oswal has come out with its earning estimates on Pharmaceuticals sector for the quarter ended March 2011. According to the research firm, Opto Circuits March quarter sales are expected to go up by 62.7% at Rs 544.3 crore, year-on-year, (YoY) basis.

  • Hits & misses in Q3: Rajesh Jain analyses 4 stocks Jan 20, 2011 01:26 PM IST

    Hits & misses in Q3: Rajesh Jain analyses 4 stocks

    Rajesh Jain, Independent Market Strategist

Sections
ISO 27001 - BSI Assurance Mark